Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer
Abstract Background Current diagnosis tools for prostate cancer (PCa) such as serum PSA detection and prostate biopsy cannot distinguish dormant tumors from invasive malignancies, either be used as prognosis marker for castration resistant prostate cancer (CRPC), the lethal stage of PCa patients. Ex...
主要な著者: | , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
BMC
2023-01-01
|
シリーズ: | Journal of Translational Medicine |
主題: | |
オンライン・アクセス: | https://doi.org/10.1186/s12967-022-03860-3 |